Literature DB >> 19423744

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

H Miles Prince, Dirk Hönemann, Andrew Spencer, David A Rizzieri, Edward A Stadtmauer, Andrew W Roberts, Nizar Bahlis, Guido Tricot, Bill Bell, Douglas J Demarini, A Benjamin Suttle, Katherine L Baker, Lini N Pandite.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19423744     DOI： 10.1182/blood-2009-02-207209

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Angiogenesis and multiple myeloma.

Authors:  Nicola Giuliani; Paola Storti; Marina Bolzoni; Benedetta Dalla Palma; Sabrina Bonomini
Journal:  Cancer Microenviron       Date:  2011-07-07

Review 2.  Not too little, not too much-just right! (Better ways to give high dose melphalan).

Authors:  P J Shaw; C E Nath; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2014-08-18       Impact factor: 5.483

Review 3.  (Pre-)clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor.

Authors:  Paul Hamberg; Jaap Verweij; Stefan Sleijfer
Journal:  Oncologist       Date:  2010-05-28

Review 4.  Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma.

Authors:  Domenico Ribatti
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-22

Review 5.  All Good Things Must End: Termination of Receptor Tyrosine Kinase Signal.

Authors:  Azzurra Margiotta
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 6.  Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.

Authors:  Wen-Chi Yang; Sheng-Fung Lin
Journal:  Biomed Res Int       Date:  2015-11-16       Impact factor: 3.411

Review 7.  Molecularly targeted therapies in multiple myeloma.

Authors:  Pilar de la Puente; Barbara Muz; Feda Azab; Micah Luderer; Abdel Kareem Azab
Journal:  Leuk Res Treatment       Date:  2014-04-16

Review 8.  New Insights in Anti-Angiogenesis in Multiple Myeloma.

Authors:  Domenico Ribatti; Angelo Vacca
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.